These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 17073741)

  • 21. Diverse physiological functions for dual-specificity MAP kinase phosphatases.
    Dickinson RJ; Keyse SM
    J Cell Sci; 2006 Nov; 119(Pt 22):4607-15. PubMed ID: 17093265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced dual-specificity phosphatase expression and AML cell survival.
    Schaar DG; Liu H; Sharma S; Ting Y; Martin J; Krier C; Ciardella M; Osman M; Goodell L; Notterman DA; Strair RK
    Leuk Res; 2005 Oct; 29(10):1171-9. PubMed ID: 16111535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression changes of growth-associated protein-43 (GAP-43) and mitogen-activated protein kinase phosphatase-1 (MKP-1) and in hippocampus of streptozotocin-induced diabetic cognitive impairment rats.
    Zhou J; Wang L; Ling S; Zhang X
    Exp Neurol; 2007 Aug; 206(2):201-8. PubMed ID: 17601561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The dual specificity phosphatase transcriptome of the murine thymus.
    Tanzola MB; Kersh GJ
    Mol Immunol; 2006 Feb; 43(6):754-62. PubMed ID: 16360020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitogen-activated protein kinase phosphatase-1 (MKP-1): >100-fold nocturnal and norepinephrine-induced changes in the rat pineal gland.
    Price DM; Chik CL; Terriff D; Weller J; Humphries A; Carter DA; Klein DC; Ho AK
    FEBS Lett; 2004 Nov; 577(1-2):220-6. PubMed ID: 15527789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Essential role of MAPK phosphatase-1 in the negative control of innate immune responses.
    Salojin KV; Owusu IB; Millerchip KA; Potter M; Platt KA; Oravecz T
    J Immunol; 2006 Feb; 176(3):1899-907. PubMed ID: 16424221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Signal transduction. History matters.
    Ingolia NT; Murray AW
    Science; 2002 Aug; 297(5583):948-9. PubMed ID: 12169717
    [No Abstract]   [Full Text] [Related]  

  • 28. Dual-specificity phosphatase 1 and serum/glucocorticoid-regulated kinase are downregulated in prostate cancer.
    Rauhala HE; Porkka KP; Tolonen TT; Martikainen PM; Tammela TL; Visakorpi T
    Int J Cancer; 2005 Dec; 117(5):738-45. PubMed ID: 15981206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of p38 MAPK by glucocorticoids via induction of MAPK phosphatase-1 enhances nontypeable Haemophilus influenzae-induced expression of toll-like receptor 2.
    Imasato A; Desbois-Mouthon C; Han J; Kai H; Cato AC; Akira S; Li JD
    J Biol Chem; 2002 Dec; 277(49):47444-50. PubMed ID: 12356755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Temporal analysis of E2 transcriptional induction of PTP and MKP and downregulation of IGF-I pathway key components in the mouse uterus.
    Ivanga M; Labrie Y; Calvo E; Belleau P; Martel C; Luu-The V; Morissette J; Labrie F; Durocher F
    Physiol Genomics; 2007 Mar; 29(1):13-23. PubMed ID: 17361005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases.
    Owens DM; Keyse SM
    Oncogene; 2007 May; 26(22):3203-13. PubMed ID: 17496916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of innate immune response by MAP kinase phosphatase-1.
    Wang X; Liu Y
    Cell Signal; 2007 Jul; 19(7):1372-82. PubMed ID: 17512700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phosphatase-mediated crosstalk control of ERK and p38 MAPK signaling in corneal epithelial cells.
    Wang Z; Yang H; Tachado SD; Capó-Aponte JE; Bildin VN; Koziel H; Reinach PS
    Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5267-75. PubMed ID: 17122112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of glucocorticoids on inflammation and arthritis.
    Morand EF
    Curr Opin Rheumatol; 2007 May; 19(3):302-7. PubMed ID: 17414960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 12-O-Tetradecanoylphorbol-13-acetate in acute myeloid leukemia.
    Chan RJ; Cripe LD
    Leuk Res; 2005 Oct; 29(10):1107-8. PubMed ID: 15913776
    [No Abstract]   [Full Text] [Related]  

  • 36. MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock.
    Zhao Q; Wang X; Nelin LD; Yao Y; Matta R; Manson ME; Baliga RS; Meng X; Smith CV; Bauer JA; Chang CH; Liu Y
    J Exp Med; 2006 Jan; 203(1):131-40. PubMed ID: 16380513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Light-inducible and clock-controlled expression of MAP kinase phosphatase 1 in mouse central pacemaker neurons.
    Doi M; Cho S; Yujnovsky I; Hirayama J; Cermakian N; Cato AC; Sassone-Corsi P
    J Biol Rhythms; 2007 Apr; 22(2):127-39. PubMed ID: 17440214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Signal transduction and protein tyrosine dephosphorylation.
    Tonks NK; Flint AJ; Gebbink MF; Sun H; Yang Q
    Adv Second Messenger Phosphoprotein Res; 1993; 28():203-10. PubMed ID: 8398405
    [No Abstract]   [Full Text] [Related]  

  • 39.
    Feng J; Meng W; Chen L; Zhang X; Markazi A; Yuan W; Huang Y; Gao SJ
    mBio; 2023 Feb; 14(1):e0334922. PubMed ID: 36625590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MAP kinase kinase kinases and innate immunity.
    Symons A; Beinke S; Ley SC
    Trends Immunol; 2006 Jan; 27(1):40-8. PubMed ID: 16356769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.